Abstract
An ideal vector for the CNS should provide long-term, stable, global distribution of the transgene with high cell specificity and low immunogenicity.
Original language | English (US) |
---|---|
Title of host publication | Advances in Non-Invasive Drug Delivery to the Brain |
Publisher | Future Medicine Ltd. |
Pages | 128-142 |
Number of pages | 15 |
ISBN (Electronic) | 9781909453937 |
ISBN (Print) | 9781909453982 |
DOIs | |
State | Published - Jun 1 2015 |
ASJC Scopus subject areas
- Pharmacology, Toxicology and Pharmaceutics(all)